Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Manipal Health EnterprisesNSE:MANIPALHOS -3.30%13 Net Margin % is 5.99% as of Mar. 2026, which is at its 10-year median of 5.99. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 671 Healthcare Providers & Services companies, Manipal Health Enterprises ranks better than 65.13% on this metric.
The historical rank and industry rank for Manipal Health Enterprises's Net Margin % or its related term are showing as below:
NSE:MANIPALHOS'
s Net Margin % Range Over the Past 10 Years
Min: 5.54 Med: 5.99 Max: 9.78
Current: 5.99
NSE:MANIPALHOS's Net Margin % is ranked better than 65.13% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: 2.91
vs NSE:MANIPALHOS: 5.99
Manipal Health Enterprises (NSE:MANIPALHOS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Manipal Health Enterprises Net Margin % Related Terms
Manipal Health Enterprises Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises Net Margin % Chart
Manipal Health Enterprises Annual Data
Trend
Mar24
Mar25
Mar26
Net Margin %
9.78
5.54
5.99
Manipal Health Enterprises Semi-Annual Data
Mar24
Mar25
Mar26
Net Margin %
9.78
5.54
5.99
NSE:MANIPALHOS vs : Net Margin % Comparison
For the Medical Care Facilities subindustry, Manipal Health Enterprises's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Manipal Health Enterprises Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's Net Margin % distribution charts can be found below:
* The bar in red indicates where Manipal Health Enterprises's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises (NSE:MANIPALHOS) has a Net Margin % of 5.99% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Manipal Health Enterprises and its competitors. This is near median its historical median of 5.99. Over the past decade, Manipal Health Enterprises' Net Margin % has ranged from 5.54 to 9.78. According to the industry distribution chart, Manipal Health Enterprises ranks #234 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 34.9%.
Is Manipal Health Enterprises' Net Margin % too high?
Manipal Health Enterprises' current Net Margin % of 5.99% is near median its 10-year median of 5.99. Over the past 10 years, this metric has ranged from a low of 5.54 to a high of 9.78. The Healthcare Providers & Services industry median Net Margin % is 2.91. Manipal Health Enterprises' value of 5.99% is 105.8% above this industry median. Based on the distribution chart, Manipal Health Enterprises ranks #234 out of 671 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' Net Margin % compare to ?
According to the Healthcare Providers & Services industry distribution chart, Manipal Health Enterprises ranks #234 out of 671 companies for Net Margin %. This puts Manipal Health Enterprises in the upper half of its industry. The industry median Net Margin % is 2.91. Manipal Health Enterprises' value of 5.99% is 105.8% above this benchmark. Historically, Manipal Health Enterprises' own Net Margin % has ranged from 5.54 to 9.78 over the past decade. While the company's 10-year median is 5.99 vs. the industry median of 2.91, Manipal Health Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.91, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Manipal Health Enterprises's current Net Margin % of 5.99% is 105.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Manipal Health Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manipal Health Enterprises's current Net Margin % is 5.99%, which is near median its own 10-year median of 5.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current Net Margin % of 5.99%. The current Net Margin % is 5.99%, which is near median its 10-year median of 5.99 and 105.8% above the Healthcare Providers & Services industry median of 2.91. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current Net Margin % is 5.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score
Get the complete analysis for NSE:MANIPALHOS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANIPALHOS has been successfully added to your 
